ELI LILLY AND COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 823.6 EUR | -0.04% |
|
-0.04% | +55.98% |
| 21/06 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
| 21/06 | Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says | RE |
Chart: Technical Analysis
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LLY Stock
- LLYC Stock
- Charts Eli Lilly and Company
